Healthcare provider profile · identity verified

Fernando Esparza, MD

Allopathic & Osteopathic Physicians|Family Medicine · MIAMI, FL · NPI 1083651178

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Fernando Esparza, MD received $16.88 in general payments during 2025 across 1 reported records.

PFIZER INC. accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 1 associated product.

PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 478 claims for Eliquis by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$16.88

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
PFIZER INC.	Unresolved — no canonical attribution shown	$16.88	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$16.88	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
PAXLOVID Normalized: paxlovid	Drug	PFIZER INC.	$16.88	1	2025
Source payment records 2025-01-09 · PFIZER INC. · $16.88 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
PFIZER INC. Exact reporting entity; no affiliate inference	2025	ELIQUIS open payments reported associated product	CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063	Eliquis · 2024 Exact normalized brand match · 1 Part D row	478	75

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1566	243
Pantoprazole Sodium	Pantoprazole Sodium	1111	149
Ssd	Silver Sulfadiazine	1111	181
Levothyroxine Sodium	Levothyroxine Sodium	1032	147
Famotidine	Famotidine	1011	147
Losartan Potassium	Losartan Potassium	956	146
Clopidogrel	Clopidogrel Bisulfate	921	117
Amlodipine Besylate	Amlodipine Besylate	803	146
Metformin Hcl	Metformin Hcl	618	114
Gabapentin	Gabapentin	602	95
Metoprolol Succinate	Metoprolol Succinate	592	95
Hydrochlorothiazide	Hydrochlorothiazide	581	108
Lisinopril	Lisinopril	546	104
Montelukast Sodium	Montelukast Sodium	512	64
Eliquis	Apixaban	478	75
Omeprazole	Omeprazole	477	77
Simvastatin	Simvastatin	438	72
Rosuvastatin Calcium	Rosuvastatin Calcium	422	64
Memantine Hcl	Memantine Hcl	403	60
Metoprolol Tartrate	Metoprolol Tartrate	390	58
Lactulose	Lactulose	385	72
Furosemide	Furosemide	380	74
Ketoconazole	Ketoconazole	368	60
Triamcinolone Acetonide	Triamcinolone Acetonide	362	72
Azithromycin	Azithromycin	295	196
Nystatin	Nystatin	292	67
Donepezil Hcl	Donepezil Hcl	291	48
Potassium Chloride	Potassium Chloride	291	52
Silver Sulfadiazine	Silver Sulfadiazine	283	88
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	276	167
Spironolactone	Spironolactone	267	41
Ciprofloxacin Hcl	Ciprofloxacin Hcl	249	162
Tamsulosin Hcl	Tamsulosin Hcl	249	43
Tizanidine Hcl	Tizanidine Hcl	244	50
Carvedilol	Carvedilol	237	42
Alendronate Sodium	Alendronate Sodium	222	30
Clotrimazole	Clotrimazole	213	42
Fluticasone Propionate	Fluticasone Propionate	209	43
Cefuroxime	Cefuroxime Axetil	197	136
Mupirocin	Mupirocin	197	47
Ammonium Lactate	Ammonium Lactate	196	25
Diclofenac Sodium	Diclofenac Sodium	195	35
Levetiracetam	Levetiracetam	190	25
Hydrocortisone	Hydrocortisone	179	29
Xarelto	Rivaroxaban	174	27
Constulose	Lactulose	171	41
Alprazolam	Alprazolam	167	29
Allopurinol	Allopurinol	164	29
Latanoprost	Latanoprost	155	27
Trazodone Hcl	Trazodone Hcl	144	39
Lantus	Insulin Glargine,hum.Rec.Anlog	143	23
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	143	20
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	137	25
Loperamide	Loperamide Hcl	135	26
Vascepa	Icosapent Ethyl	123	17
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	118	24
Hydralazine Hcl	Hydralazine Hcl	117	17
Linzess	Linaclotide	112	17
Cholestyramine	Cholestyramine (With Sugar)	109	19
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	108	24
Glipizide	Glipizide	108	25
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	103	20
Finasteride	Finasteride	101	17
Meclizine Hcl	Meclizine Hcl	101	21
Bumetanide	Bumetanide	99	18
Temazepam	Temazepam	97	13
Sucralfate	Sucralfate	96	19
Clonazepam	Clonazepam	94	19
Albuterol Sulfate Hfa	Albuterol Sulfate	93	28
Entresto	Sacubitril/Valsartan	93	14
Baclofen	Baclofen	91	13
Quetiapine Fumarate	Quetiapine Fumarate	88	19
Carbidopa-Levodopa	Carbidopa/Levodopa	86	16
Nifedipine Er	Nifedipine	85	18
Enulose	Lactulose	81	18
Tramadol Hcl	Tramadol Hcl	78	23
Prednisone	Prednisone	74	27
Methenamine Hippurate	Methenamine Hippurate	73	suppressed
Clonidine Hcl	Clonidine Hcl	71	14
Levofloxacin	Levofloxacin	67	61
Lorazepam	Lorazepam	67	14
Amantadine	Amantadine Hcl	65	suppressed
Atenolol	Atenolol	65	12
Oxybutynin Chloride	Oxybutynin Chloride	64	12
Buspirone Hcl	Buspirone Hcl	63	14
Pravastatin Sodium	Pravastatin Sodium	63	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	62	12
Vitamin D2	Ergocalciferol (Vitamin D2)	62	12
Glimepiride	Glimepiride	59	18
Cyproheptadine Hcl	Cyproheptadine Hcl	57	14
Timolol Maleate	Timolol Maleate	56	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	55	18
Digoxin	Digoxin	51	suppressed
Nitroglycerin	Nitroglycerin	51	suppressed
Cholestyramine Light	Cholestyramine	50	suppressed
Levemir	Insulin Detemir	50	17
Santyl	Collagenase Clostridium Hist.	47	17
Amiodarone Hcl	Amiodarone Hcl	46	suppressed
Mirtazapine	Mirtazapine	46	13
Alcohol Prep Pads	Alcohol Antiseptic Pads	45	11
Insulin Syringe	Syringe And Needle,insulin,1ml	45	suppressed
Nystop	Nystatin	45	suppressed
Propranolol Hcl	Propranolol Hcl	45	suppressed
Glipizide Er	Glipizide	44	11
Enalapril Maleate	Enalapril Maleate	43	suppressed
Ezetimibe	Ezetimibe	43	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	16
Olmesartan Medoxomil	Olmesartan Medoxomil	41	suppressed
Pregabalin	Pregabalin	41	suppressed
Erythromycin	Erythromycin Base	40	16
Permethrin	Permethrin	40	14
Folic Acid	Folic Acid	39	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	37	suppressed
Ondansetron Hcl	Ondansetron Hcl	37	17
Sotalol	Sotalol Hcl	37	suppressed
Acyclovir	Acyclovir	36	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	suppressed
Sertraline Hcl	Sertraline Hcl	36	11
Sure Comfort	Syringe-Needle,insulin,0.5 Ml	36	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	35	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	suppressed
Lovastatin	Lovastatin	35	suppressed
Brilinta	Ticagrelor	34	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	33	suppressed
Ibuprofen	Ibuprofen	32	11
Restasis	Cyclosporine	32	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	31	16
Tresiba Flextouch U-100	Insulin Degludec	31	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	24
Oxcarbazepine	Oxcarbazepine	30	suppressed
Azelastine Hcl	Azelastine Hcl	29	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	29	suppressed
Cefdinir	Cefdinir	29	26
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	29	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	29	suppressed
Meloxicam	Meloxicam	29	suppressed
Procto-Med Hc	Hydrocortisone	29	suppressed
Ciclopirox	Ciclopirox	28	11
Naproxen	Naproxen	28	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	28	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	28	suppressed
Combigan	Brimonidine Tartrate/Timolol	27	suppressed
Midodrine Hcl	Midodrine Hcl	27	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	27	suppressed
Pentoxifylline	Pentoxifylline	27	suppressed
Lamotrigine	Lamotrigine	26	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	26	11
Celecoxib	Celecoxib	25	suppressed
Tradjenta	Linagliptin	25	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	25	suppressed
Amikacin Sulfate	Amikacin Sulfate	24	17
Icosapent Ethyl	Icosapent Ethyl	24	12
Januvia	Sitagliptin Phosphate	24	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	24	19
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Trueplus Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	24	suppressed
Duloxetine Hcl	Duloxetine Hcl	23	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	23	suppressed
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	23	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	22	14
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Methimazole	Methimazole	22	suppressed
Metronidazole	Metronidazole	22	12
Risperidone	Risperidone	22	suppressed
Tresiba	Insulin Degludec	22	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Galantamine Hbr	Galantamine Hbr	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Ceftriaxone	Ceftriaxone Sodium	20	15
Creon	Lipase/Protease/Amylase	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Halobetasol Propionate	Halobetasol Propionate	20	suppressed
Labetalol Hcl	Labetalol Hcl	20	suppressed
Nitroglycerin Patch	Nitroglycerin	20	suppressed
Torsemide	Torsemide	20	suppressed
Novolin R	Insulin Regular, Human	19	suppressed
Nyamyc	Nystatin	19	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	19	suppressed
Solifenacin Succinate	Solifenacin Succinate	19	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Admelog	Insulin Lispro	18	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	18	suppressed
Irbesartan	Irbesartan	18	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	18	suppressed
Novolin N	Insulin Nph Human Isophane	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Primidone	Primidone	18	suppressed
Mometasone Furoate	Mometasone Furoate	17	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	17	suppressed
Unifine Pentips	Pen Needle, Diabetic	17	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	16	suppressed
Cephalexin	Cephalexin	16	16
Divalproex Sodium Er	Divalproex Sodium	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Memantine Hcl Er	Memantine Hcl	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	15
Novolog Mix 70-30	Insulin Aspart Prot/Insuln Asp	16	suppressed
Proctozone-Hc	Hydrocortisone	16	suppressed
Ranolazine Er	Ranolazine	16	suppressed
Valsartan	Valsartan	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Bethanechol Chloride	Bethanechol Chloride	15	suppressed
Divalproex Sodium	Divalproex Sodium	15	suppressed
Lidocaine Hcl	Lidocaine Hcl	15	11
Candesartan Cilexetil	Candesartan Cilexetil	14	suppressed
Fenofibrate	Fenofibrate,micronized	14	suppressed
Humalog Mix 75-25	Insulin Lispro Protamin/Lispro	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Calcitriol	Calcitriol	13	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Lacosamide	Lacosamide	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	13	suppressed
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	12	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Multaq	Dronedarone Hcl	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Propafenone Hcl	Propafenone Hcl	12	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Tobramycin	Tobramycin	12	suppressed
Cyclosporine	Cyclosporine	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Fluocinonide	Fluocinonide	11	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	11	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	11	suppressed
Veo Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$16.88 · 1 records	PFIZER INC.	PAXLOVID	1	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with PFIZER INC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error